4AB:FRA
AbbVie Common Stock
€265,40
arrow_downward
-0,45%(-1,20) 1D
18 ພ.ຈ., 8 ໂມງ 1 ນາທີ 11 ວິນາທີ GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€265,40
High
€265,40
Low
€265,40
Mkt. cap
517,59 ຕື້
Avg. vol.
109,00
Volume
0,00
52-wk high
€272,30
52-wk low
€167,55
No. of employees
57 ພັນ
Open
€265,40
High
€265,40
Low
€265,40
Mkt. cap
517,59 ຕື້
Avg. vol.
109,00
Volume
0,00
52-wk high
€272,30
52-wk low
€167,55
No. of employees
57 ພັນ
News stories
From web sources and news partners
Zacks Investment Research
·
13 ຊົ່ວໂມງກ່ອນ
How Did AbbVie's Neuroscience Franchise Perform in Q3?
The Globe and Mail
·
21 ຊົ່ວໂມງກ່ອນ
Barclays Reaffirms Their Buy Rating on AbbVie (ABBV)
Smartkarma
·
4 ມື້ກ່ອນ
AbbVie Raises 2026 Revenue Guidance to $67.8 Billion: Can Skyrizi and Rinvoq Sustain Growth?
WSJ
·
2 ອາທິດກ່ອນ
AbbVie Revenue Rises on Strength in Immunology, Neuroscience
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 ພັນ
Founded10 ມ.ສ. 2012
HeadquartersNorth Chicago, ອິລິນອຍ, ສະຫະລັດ
SectorHealth Care
IndustryBiotechnology
Websiteabbvie.com